Dec 31, 2021

Revolution Medicines Q4 2021 Earnings Report

Total Revenue
$9.46M
Previous year: $8.75M
+8.1%
EPS
-$0.71
Previous year: -$0.52
+36.5%
Gross Profit
$7.4M
Previous year: -$28.3M
-126.2%
Cash and Equivalents
$108M
Previous year: $104M
+4.1%
Free Cash Flow
-$40.4M
Previous year: -$26.2M
+54.4%
Total Assets
$738M
Previous year: $567M
+30.1%

Revolution Medicines

Revolution Medicines